Literature DB >> 2292173

Considerations in the use of intravenous immune globulin products.

.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2292173

Source DB:  PubMed          Journal:  Clin Pharm        ISSN： 0278-2677


× No keyword cloud information.
  3 in total

Review 1.  Considerations for dosing immunoglobulin in obese patients.

Authors:  J P Hodkinson
Journal:  Clin Exp Immunol       Date:  2017-04-17       Impact factor: 4.330

Review 2.  Subcutaneous immunoglobulin: opportunities and outlook.

Authors:  S Misbah; M H Sturzenegger; M Borte; R S Shapiro; R L Wasserman; M Berger; H D Ochs
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

3.  Therapeutic immunoglobulin should be dosed by clinical outcome rather than by body weight in obese patients.

Authors:  J P Hodkinson; M Lucas; M Lee; M Harrison; M P Lunn; H Chapel
Journal:  Clin Exp Immunol       Date:  2015-05-25       Impact factor: 4.330
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.